Literature DB >> 18084261

What does serum fibroblast growth factor 23 do in hemodialysis patients?

M Emmett1.   

Abstract

Fibroblast growth factor 23 (FGF-23) is a phosphate-regulating substance largely produced by osteocytes. Its major action, in normal subjects, is the inhibition of Na-coupled reabsorption of inorganic phosphate in the renal proximal tubule. FGF-23 levels increase markedly in dialysis patients. Why do the FGF-23 levels increase in these patients, and do they have any physiologic or pathophysiologic effects?

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18084261     DOI： 10.1038/sj.ki.5002651

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  6 in total

1.  Characterization of mandibular bone in a mouse model of chronic kidney disease.

Authors:  Melissa M Lee; Emily Y Chu; Mohga M El-Abbadi; Brian L Foster; Kevin A Tompkins; Cecilia M Giachelli; Martha J Somerman
Journal:  J Periodontol       Date:  2010-02       Impact factor: 6.993

Review 2.  Management of secondary hyperparathyroidism in the elderly patient with chronic kidney disease.

Authors:  Mario Cozzolino; Maurizio Gallieni; Sabina Pasho; Giuditta Fallabrino; Paola Ciceri; Elisa Maria Volpi; Laura Olivi; Diego Brancaccio
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

3.  Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation.

Authors:  Pieter Evenepoel; Bjorn K I Meijers; Hylke de Jonge; Maarten Naesens; Bert Bammens; Kathleen Claes; Dirk Kuypers; Yves Vanrenterghem
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-15       Impact factor: 8.237

Review 4.  Kidney disease outcomes quality initiative guidelines for bone and mineral metabolism: emerging questions.

Authors:  Tejas V Patel; Ajay K Singh
Journal:  Semin Nephrol       Date:  2009-03       Impact factor: 5.299

5.  Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin.

Authors:  Mohga M El-Abbadi; Ashwini S Pai; Elizabeth M Leaf; Hsueh-Ying Yang; Bryan A Bartley; Krystle K Quan; Carly M Ingalls; Hung Wei Liao; Cecilia M Giachelli
Journal:  Kidney Int       Date:  2009-03-25       Impact factor: 10.612

6.  FGF23 is associated with early post-transplant hypophosphataemia and normalizes faster than iPTH in living donor renal transplant recipients: a longitudinal follow-up study.

Authors:  Narayan Prasad; Akhilesh Jaiswal; Vikas Agarwal; Shashi Kumar; Saurabh Chaturvedi; Subhash Yadav; Amit Gupta; Raj K Sharma; Dharmendra Bhadauria; Anupama Kaul
Journal:  Clin Kidney J       Date:  2016-07-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.